Hepatitis D medical therapy: Difference between revisions
Jump to navigation
Jump to search
Joao Silva (talk | contribs) |
Joao Silva (talk | contribs) |
||
| Line 8: | Line 8: | ||
==Medical Therapy== | ==Medical Therapy== | ||
The goal of treatment in hepatitis D is the clearance of the HDV and of the hepatitis B helper virus. The complexity of the treatment resides in the need to address two viruses, and in the simplicity of the HDV, which limits the number of targets for therapeutic agents. | The goal of treatment in hepatitis D is the clearance of the HDV and of the hepatitis B helper virus. The complexity of the treatment resides in the need to address two viruses, and in the simplicity of the HDV, which limits the number of targets for therapeutic agents. | ||
==References== | ==References== | ||
Revision as of 15:44, 6 August 2014
|
Hepatitis D |
|
Diagnosis |
|
Treatment |
|
Hepatitis D medical therapy On the Web |
|
American Roentgen Ray Society Images of Hepatitis D medical therapy |
|
Risk calculators and risk factors for Hepatitis D medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Varun Kumar, M.B.B.S. [2]; João André Alves Silva, M.D. [3] Jolanta Marszalek, M.D. [4]
Overview
Medical Therapy
The goal of treatment in hepatitis D is the clearance of the HDV and of the hepatitis B helper virus. The complexity of the treatment resides in the need to address two viruses, and in the simplicity of the HDV, which limits the number of targets for therapeutic agents.